[1] |
潘钢芸. 妇科常见肿瘤的类型与特点[N]. 甘肃科技报,2024-04-22(06).
|
[2] |
冯征, 郭勤浩, 朱俊, 等. 2023年度妇科恶性肿瘤治疗进展及展望[J]. 中国癌症杂志, 2024, 34(4):340-360. doi: 10.19401/j.cnki.1007-3639.2024.04.002.
|
[3] |
Bahuguna A, Dubey SK. Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics[J]. Biochim Biophys Acta Rev Cancer, 2023, 1878(5): 188956. doi: 10.1016/j.bbcan.2023.188956.
|
[4] |
卿雪梅, 张勇. 阴道微生态失调之细菌性阴道病的研究进展[J]. 四川医学, 2024, 45(10):1160-1164. doi: 10.16252/j.cnki.issn1004-0501-2024.10.022.
|
[5] |
向湘, 王妍, 陈佳乐, 等. 阴道菌群在妇科疾病中的研究进展[J]. 社区医学杂志, 2023, 21(10):540-544. doi: 10.19790/j.cnki.JCM.2023.10.11.
|
[6] |
艾雯霞, 李东慧, 亓丁, 等. 细菌性阴道病最新诊断及治疗方案的研究进展[J]. 检验医学与临床, 2024, 21(9):1326-1331. doi: 10.3969/j.issn.1672-9455.2024.09.030.
|
[7] |
丁丽, 罗晓华, 田野, 等. 阴道菌群与女性生殖道健康[J]. 河南预防医学杂志, 2021, 32(11):801-804,808. doi: 10.13515/j.cnki.hnjpm.1006-8414.2021.11.001.
|
[8] |
Xu H, Zhang S, Zhang B, et al. Vaginal colonization of Lactobacilli: Mechanism and function[J]. Microb Pathog, 2025,198:107141. doi: 10.1016/j.micpath.2024.107141.
|
[9] |
Avitabile E, Menotti L, Croatti V, et al. Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections[J]. Int J Mol Sci, 2024, 25(17):9168. doi: 10.3390/ijms25179168.
|
[10] |
Bnfaga AA, Lee KW, Than L, et al. Antimicrobial and immunoregulatory effects of Lactobacillus delbrueckii 45E against genitourinary pathogens[J]. J Biomed Sci, 2023, 30(1):19. doi: 10.1186/s12929-023-00913-7.
pmid: 36959635
|
[11] |
Ottinger S, Robertson CM, Branthoover H, et al. The human vaginal microbiota: from clinical medicine to models to mechanisms[J]. Curr Opin Microbiol, 2024,77:102422. doi: 10.1016/j.mib.2023.102422.
|
[12] |
毛雪涛. 子宫肌瘤与肠道和生殖道菌群相关性的初步研究[D]. 长沙: 中南大学, 2023.
|
[13] |
Jacobson D, Moore K, Gunderson C, et al. Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer[J]. PeerJ, 2021,9:e11574. doi: 10.7717/peerj.11574.
|
[14] |
Yu T, Gao S, Jin F, et al. Characteristics of the vaginal microbiota and vaginal metabolites in women with cervical dysplasia[J]. Front Cell Infect Microbiol, 2024,14:1457216. doi: 10.3389/fcimb.2024.1457216.
|
[15] |
Semertzidou A, Whelan E, Smith A, et al. Microbial signatures and continuum in endometrial cancer and benign patients[J]. Microbiome, 2024, 12(1):118. doi:10.1186/s40168-024-01821-0.
pmid: 38951935
|
[16] |
Yang L, Li A, Wang Y, et al. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy[J]. Signal Transduct Target Ther, 2023, 8(1):35. doi: 10.1038/s41392-022-01304-4.
|
[17] |
曾芳. 阴道用乳杆菌活菌胶囊联合抗菌治疗对细菌性阴道病患者阴道微生态及复发的影响[J]. 中国医学创新, 2024, 21(23):100-104. doi: 10.3969/j.issn.1674-4985.2024.23.024.
|
[18] |
Lev-Sagie A, Goldman-Wohl D, Cohen Y, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis[J]. Nat Med, 2019, 25(10):1500-1504. doi: 10.1038/s41591-019-0600-6.
pmid: 31591599
|